UDP-003, a cyclodextrin-based drug, safely reduces 7-ketocholesterol in Phase 1, potentially reversing atherosclerosis instead of just slowing it. A novel drug that removes toxic cholesterol byproduct...
7-ketocholesterol (7KC), an oxidized cholesterol, is linked to cardiovascular and neurodegenerative diseases, with recent AI diagnostics and clinical trials advancing preventive healthcare for aging p...
